These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26180100)

  • 21. A novel nonviral gene delivery system for treating Leber's congenital amaurosis.
    Sun D; Schur RM; Lu ZR
    Ther Deliv; 2017 Oct; 8(10):823-826. PubMed ID: 28944740
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.
    Stein L; Roy K; Lei L; Kaushal S
    Expert Opin Biol Ther; 2011 Mar; 11(3):429-39. PubMed ID: 21299439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preserved outer retina in AIPL1 Leber's congenital amaurosis: implications for gene therapy.
    Aboshiha J; Dubis AM; van der Spuy J; Nishiguchi KM; Cheeseman EW; Ayuso C; Ehrenberg M; Simonelli F; Bainbridge JW; Michaelides M
    Ophthalmology; 2015 Apr; 122(4):862-4. PubMed ID: 25596619
    [No Abstract]   [Full Text] [Related]  

  • 24. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.
    Maguire AM; High KA; Auricchio A; Wright JF; Pierce EA; Testa F; Mingozzi F; Bennicelli JL; Ying GS; Rossi S; Fulton A; Marshall KA; Banfi S; Chung DC; Morgan JI; Hauck B; Zelenaia O; Zhu X; Raffini L; Coppieters F; De Baere E; Shindler KS; Volpe NJ; Surace EM; Acerra C; Lyubarsky A; Redmond TM; Stone E; Sun J; McDonnell JW; Leroy BP; Simonelli F; Bennett J
    Lancet; 2009 Nov; 374(9701):1597-605. PubMed ID: 19854499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leber congenital amaurosis: Current genetic basis, scope for genetic testing and personalized medicine.
    Kondkar AA; Abu-Amero KK
    Exp Eye Res; 2019 Dec; 189():107834. PubMed ID: 31639339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy.
    Pennesi ME; Weleber RG; Yang P; Whitebirch C; Thean B; Flotte TR; Humphries M; Chegarnov E; Beasley KN; Stout JT; Chulay JD
    Hum Gene Ther; 2018 Dec; 29(12):1428-1437. PubMed ID: 29869534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.
    Chiu W; Lin TY; Chang YC; Isahwan-Ahmad Mulyadi Lai H; Lin SC; Ma C; Yarmishyn AA; Lin SC; Chang KJ; Chou YB; Hsu CC; Lin TC; Chen SJ; Chien Y; Yang YP; Hwang DK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual acuity in patients with Leber's congenital amaurosis and early childhood-onset retinitis pigmentosa.
    Walia S; Fishman GA; Jacobson SG; Aleman TS; Koenekoop RK; Traboulsi EI; Weleber RG; Pennesi ME; Heon E; Drack A; Lam BL; Allikmets R; Stone EM
    Ophthalmology; 2010 Jun; 117(6):1190-8. PubMed ID: 20079931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudo-fovea formation after gene therapy for RPE65-LCA.
    Cideciyan AV; Aguirre GK; Jacobson SG; Butt OH; Schwartz SB; Swider M; Roman AJ; Sadigh S; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):526-37. PubMed ID: 25537204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis.
    Hussain RM; Tran KD; Maguire AM; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):661-663. PubMed ID: 31671202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy: perspectives from young adults with Leber's congenital amaurosis.
    Napier MP; Selvan K; Hayeems RZ; Shuman C; Chitayat D; Sutherland JE; Day MA; Héon E
    Eye (Lond); 2022 Nov; 36(11):2088-2093. PubMed ID: 34531550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse Models as Tools to Identify Genetic Pathways for Retinal Degeneration, as Exemplified by Leber's Congenital Amaurosis.
    Chang B
    Methods Mol Biol; 2016; 1438():417-30. PubMed ID: 27150101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. fMRI of retina-originated phosphenes experienced by patients with Leber congenital amaurosis.
    Ashtari M; Cyckowski L; Yazdi A; Viands A; Marshall K; Bókkon I; Maguire A; Bennett J
    PLoS One; 2014; 9(1):e86068. PubMed ID: 24465873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leber's Congenital Amaurosis: Current Concepts of Genotype-Phenotype Correlations.
    Huang CH; Yang CM; Yang CH; Hou YC; Chen TC
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment Potential for Macular Cone Vision in Leber Congenital Amaurosis Due to CEP290 or NPHP5 Mutations: Predictions From Artificial Intelligence.
    Sumaroka A; Garafalo AV; Semenov EP; Sheplock R; Krishnan AK; Roman AJ; Jacobson SG; Cideciyan AV
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2551-2562. PubMed ID: 31212307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2.
    Testa F; Maguire AM; Rossi S; Pierce EA; Melillo P; Marshall K; Banfi S; Surace EM; Sun J; Acerra C; Wright JF; Wellman J; High KA; Auricchio A; Bennett J; Simonelli F
    Ophthalmology; 2013 Jun; 120(6):1283-91. PubMed ID: 23474247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year.
    Cideciyan AV; Hauswirth WW; Aleman TS; Kaushal S; Schwartz SB; Boye SL; Windsor EA; Conlon TJ; Sumaroka A; Pang JJ; Roman AJ; Byrne BJ; Jacobson SG
    Hum Gene Ther; 2009 Sep; 20(9):999-1004. PubMed ID: 19583479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy using self-complementary Y733F capsid mutant AAV2/8 restores vision in a model of early onset Leber congenital amaurosis.
    Ku CA; Chiodo VA; Boye SL; Goldberg AF; Li T; Hauswirth WW; Ramamurthy V
    Hum Mol Genet; 2011 Dec; 20(23):4569-81. PubMed ID: 21880665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.
    Hauswirth WW; Aleman TS; Kaushal S; Cideciyan AV; Schwartz SB; Wang L; Conlon TJ; Boye SL; Flotte TR; Byrne BJ; Jacobson SG
    Hum Gene Ther; 2008 Oct; 19(10):979-90. PubMed ID: 18774912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Therapy of Dominant CRX-Leber Congenital Amaurosis using Patient Stem Cell-Derived Retinal Organoids.
    Kruczek K; Qu Z; Gentry J; Fadl BR; Gieser L; Hiriyanna S; Batz Z; Samant M; Samanta A; Chu CJ; Campello L; Brooks BP; Wu Z; Swaroop A
    Stem Cell Reports; 2021 Feb; 16(2):252-263. PubMed ID: 33513359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.